Blood-vessel cells in cancerous growths in the body help stave off immune-based cancer treatments, Swedish researchers said Monday.
The research suggests that cells found in the blood vessels of malignant growths curb the body's own method of fighting cancer cells, Karolinska Institutet said in a press release.
"Understanding the interplay between tumor pericytes, malignant cells, and the immune system might help in designing more personalized and effective therapeutic approaches," said Guillem Genove, one of the researchers behind the study.
Tumors escape the treatment by suppressing the ability of killer T cells, often used in immunotherapy, to destroy cancer cells.
The study, published in the Journal of the National Cancer Institute, found that a lower number of pericytes -- a cell that is part of the tumor blood vessels -- correlates to a higher presence of cells that suppress the body's cancer-fighting mechanism.
Cancer treatments that strengthen the body's own response to cancer have in recent years found success in repressing diagnoses such as malignant melanoma.
GMT 11:00 2018 Tuesday ,20 November
Iraqi children continue to suffer conflict, inequality in last 7 yearsGMT 18:15 2018 Wednesday ,05 September
Shaikh Khalid bin Hamad receives Bahraini researcherGMT 22:05 2018 Monday ,15 January
DERASAT ranked among top five Arab research centresGMT 04:26 2018 Tuesday ,09 January
IES honored with Meritorious AIP Best Performing School Award 2017GMT 22:21 2018 Monday ,01 January
Works minister receives researcherGMT 00:07 2017 Tuesday ,26 December
Study on thermal insulation presentedGMT 10:31 2017 Wednesday ,20 December
‘Turkish Corner’ to help students, researchers understand Turkish cultureGMT 08:35 2017 Sunday ,19 November
AGU showcases international research in medical computer simulationMaintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2021 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2021 ©
Send your comments
Your comment as a visitor